Комбинированное лечение далекозашедших и резистентных форм ретинобластомы
Диссертация
До середины XX века дети, страдающие ретинобластомой, имели мало шансов на выживание. Современное комбинированное лечение РБ позволяет увеличить выживаемость детей с РБ до 95%. Усовершенствование лучевых технологий, внедрение новых лекарственных препаратов с различными протоколами лечения сыграли ключевую роль в революционном снижении смертности. Основное направление в современном лечении РБ… Читать ещё >
Список литературы
- Аветисов Э.С., Ковалевский Е. И., Хватова A.B., // Руководство по детский офтальмологии. М., Медицина, 1987. 440 с.
- Алексеева Т.А. диагностика и тактика ведения ретинобластом у детей // опухоли и опухолеподобные заболевания органа зрения. М., 1990. С. 55−56.
- Бархаш С.А., Тринчук В. В., Клиника и лечение органа зрение у детей // опухоли глаза, его придатков и орбиты, 1978. 232 с.
- Белкина Б. М. Клиника, диагностика и лечение ретинобластомы у детей. // Дисс. док. мед. наук. М., 1993. 238 с.
- Бровкина А.Ф. Ретинобластома // наследственные и врожденные заболевания сетчатки и зрительного нерва (под ред. A.M. Шамшиновой). М., 2001. -С 360−372.
- Бровкина А.Ф. // Руководство по офтальмоонкологии. М., Медицина, 2002. -421с.
- Бровкина А.Ф., Пантелеева О. Г. Результаты лечения ретинобластомы. // «Вестник офтальмологии», 1995. № 3. — С. 12 -14.
- Бровкина А.Ф., Саакян С. В. Первый опыт лечения ретинобластомы новой схемой полихимиотерапии // Материалы Всероссийской конференции «Опухоли и опухолеподобные заболевания органа зрения». М., 1998. С 84 — 85.
- Ю.Бровкина А. Ф., Саакян С. В., Пантелеева О. Г. Лечение ретинобластомы. // Пособие для врачей. М., 1996. 10 с.
- П.Вальский В. В. Компьютерная томография в диагностике, планировании и оценке эффективности лечения заболеваний органа зрения: Дис. д-ра мед. наук. М., 1998. 195 с.
- Голдобенко, Г. В. Дурное Л.А., Белкина Б. М. и др. Ретинобластома. //Учебник «Детская онкология». М., 2002. Глава 18. С. 413−438.
- Дурнов Л.А., Белкина Б. М., Поляков В. Г. и др. Комплексное лечение ретинобластомы у детей // Вестн. Рос. АМН, 1996. № 10. — С.28−33.
- Зуева М.В. Созревание и пластичность зрительной системы: нейрогенез, си-наптогенез и миелиногенез. II. Зрительная кора и зрительная лучистость // Вестник офтальмологии, 20 126. Т 128, № 4. — С. 70−74.
- Катькова Е. А. Ультразвуковая диагностика объемных процессов органа зрения //1-е издание М. ЮОО «Фирма СТРОМ», 2011. — 384 с.
- Ковалевский Е.И., Нурмамедов H.H., Дурнов JI.A. // Детские глазные опухоли М., 1985.- 148 с.
- Ковалевский Е.И., Фаустов B.C., Белкина Б. М., Новый биохимический тест для ранней дифференциальной диагностики ретинобластом у детей // Вестник офтальмологии, 1973. -№ 2 С. 30−34.
- Лобанов Г. В., Голдобенко Г. В. Лучевая терапия двухсторонней ретинобла-стомы// Офтальмол. Журнал, 1988. -№ 1.-С.15.
- Пантелеева О.Г. Ретинобластома: прогностическая значимость клинических симптомов, эффективность комбинированного лечения. Дисс. канд. мед. наук. Москва-1997. 165с.
- Поддубная И.В. Лекарственная терапия злокачественных опухолей: современное состояние и перспективы // Русский медицинский журнал, 1999. -Т 6,№ 10,-С.621−627.
- Поляков В.Г. Ретинобластома у детей.// Энциклопедия клинической онкологии. М., Издательская группа РОНЦ, 2004. — Глава 5.27.13. — С. 767−771.
- Родин A.C. Биомикроретинометрия. Теоретические основы работы на оптическом когерентном томографе сетчатки и принципы интерпретации томографических изображений // Офтальмология, 2006. Т 3, № 2. — С.81−87.
- Саакян C.B. Ранняя диагностика и лечение ретинобластомы. Дисс. док. мед. наук. М., 2002. 259 с.
- Саакян C.B. Ретинобластома (клиника, диагностика, лечение) // М.: «Медицина», 2005 200с.
- Тимакова В. И., Фридман Ф. Е., Хватова A.B., Ультразвуковое сканирование при диагностике ретинобластом // Вестник офтальмологии, 1982. № 5 — С. 71−73.
- Хватова А.В., Вайнштейн Е. И., Чернов В. Н., Дмитровская И.П., Желудкова
- B.В., Бурдянская Е. И., Сорокина М. Н., Тимакова В. И. Органосохранное лечение ретинобластом //Диагностика и лечение внутриглазных опухолей: Материалы международного симпозиума по офтальмологии. М., 1986.1. C.108−111.
- Щуко А.Г., Малышева В. В. Оптическая когерентная томография в офтальмологии. Иркутск, 2005. — 110с.
- Abramson D.H. Chemosurgery for retinoblastoma: what we know after 5 years // Arch. Ophthalmol, 2011. V 129, N 11. — P. 1492−1494.
- Abramson D.H., Dunkel I., Brodie S.E. et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results // Ophthalmology, 2008. V 115, N 8. — P. 1398−1404.
- Abramson D.H., Dunkel I., Brodie S.E. et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery) // Ophthalmology, 2010. V 117, N 8. — P. 1623−1629.
- Abramson D.H., Dunkel I.J., Brodie S.E. et al. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy // Arch. Ophthalmol, 2010. V 128, N 3. — P. 370−372.
- Abramson D.H., Frank C. M., Susman M. et al: Presenting signs of Retinoblastoma: J. of Pediatrics, 1998. V 132. — P 505−508.
- Abramson D.H., Marr B.P., Dunkel I.J. et al. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding // Brit.J. Ophthalmol, 2012.-V 96.-P. 499−502.
- Abramson D.H., Schefler A.C. Update on retinoblastoma. Retina, 2004. V 24, N 6. — P.828- 848.
- Abramson D.H., Dunkel I.J., Brodie S.E. et al. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.// Arch Ophthalmol, 2010. V 128, N 3. -P. 370−372.
- Abramson D.H., Dunkel I.J., Brodie S.E. et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery) // Ophthalmology, 2010. -V 117, N 8. -P. 1623−1629
- Abramson D.H., Frank C.M., Dunkel I.J. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma // Ophthalmology, 1999. -V 106. P. 1947−1950.
- Abramson D.H. Retinoblastoma in the 20th century: past success and future challenges. The Weisenfeld Lecture. Invest. Ophthalmol. Vis. Sei. 2005. V 46. -P. 2683−2691.
- Abramson, D.H., Niksarli K., Ellsworth R.M., Servodido C.A., Changing trends in the management of retinoblastoma: 1951−1965, 1966−1980 // J Pediatr Ophthalmol Strabismus., 1994. -V 31, N1. P. 32−37.
- Advani S. H,. Rao S.R., Iyer R.S. et al. Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma // Med. Pediatr. Oncol, 1994. -V 22, N2. -P.125−128.
- Allen J., Siffert J., Donahue B., Nirenberg A. A phase S study carboplatin combined with hyperfractionated radiotherapy for brainsteem gliomas // Cancer, 1999. V 86, N 6. P. 1064−1069.
- Anderson P.M., Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas // Curr Oncol Rep, 2006. V 8. P. 310−15.
- Bechrakis N.E., Bornfeld N., Schueler A. et al. Clinicopathologic features of retinoblastoma after primary chemoreduction // Arch. Ophthalmol, 1998. V 116. -P. 887−893.
- Beck M.N., Balmer A. et al. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma // J. Clin.Oncol., 2000. V 18, N 15. — P. 2881−2887.
- Bhisitrul R.B., Mukai S. Emerging chemotherapeutic strategies in the managements of intraocular retinoblastoma // Chemotherapy for retinoblastoma, 1997. -P. 201−215.
- Brodie S.E., Gobin P.Y., Dunkel L.I., Kim J.W., Abramson D.H. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma // Doc. Ophthalmol, 2009. V 119, N 1. — P. 13−22.
- Brodie S.E., Gobin Y.P., Магг B.P., Dunkel I., Abramson D.H. ERG Monitoring of retinal function after super-selective intra-arterial chemotherapy for retinoblastoma: 3-year results // ARVO 2010 Abstract 3277/A593.
- Brodie S.E., Paulus Y.M., Patel M., Gobin Y.P. et al. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma // Brit. J. Ophthalmol., 2012. V 96, N 6. — P. 877−880.
- Byrne S.F., Green R.L. Ultrasound of the eye and orbit. Mosby Inc., Philadelphia, USA, 2002. 505 p.
- Carol L., Shields and Jerry A Shields MD. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey Clinical and Experimental // Ophthalmology, 2010. V 38. — P 638−643.
- Chan H.S.L., Thorner P. S., Haddad G., Gallie B.L. Effect of chemotherapy on intraocular retinoblastoma // Int. J. Pediatr Hematol. Oncol, 1995. V 2. P 269 281.
- Demirci H., Shields C.L., Meadows A.T., Shields J.A. Long-term visual outcome following chemoreduction for retinoblastoma // Arch. Ophthalmol, 2005. V 123. -P. 1525−1530.
- Der Kinderen D.J., Koten J.N., Van Romunde L.K., Nagelkerke N.J., et. al. Early diagnosis of bilater retinoblastoma reduces death and blindness // Int. J. Cancer, 1989.-V 44, N 1. P. 35−39
- Desjardins L., Chefchaouni M.C., Lumbroso L. et al. Functional results after treatment of retinoblastoma // J. AAPOS, 2002. V 6. — P. 108−111.
- Desjardins L., Les tumeurs en opthalmo-pediatrie. Diagnostic et strategie therapeutique// J.Fr Ophthalmol., 2000. V 23, N 9. — P. 926−939.
- Desjardins L., Levy C., Lumbroso L., Doz F. et al. Le traitement actuel du retinoblastoma. 153 enfants traits entre 1995 et 1998 // J. Fr. Ophthalmol, 2000. -V 23, N5. P.475−481.
- Dimaras H., Mallipatna A.C., Gallie B.L., Chan H.S.L. Chemotherapy focal therapy and beyond the importance of clinical trials and the role of retinoblastoma clinical studies conglomerate // XV th Biannual meeting ISOO 2011.- Abstract book.- P .35.
- Doz F., Neuenschwander S., Plantaz D. et al. Etoposide and carboplatin in extra ocular retinoblastoma: a study by the societe Francaise D’oncologic Pediatrique // J. Clin. Oncol, 1995. -V 1, N4. P. 902−909.
- Draper G. J., Sanders B. M., Kingston J. E., Second primary neoplasms in patients with retinoblastoma // Br. J. Cancer, 1986. -V 53. P. 661−667.
- Duangnate Rojanaporn, Kaliki S., Bianciotto C.G., Iturralde J. C., Say E.A., Shields C.L., Intravenous Chemoreduction or Intra-arterial Chemotherapy for Cavitary Retinoblastoma // Arch Ophthalmol, 2012. -V 130, N 5. P 585−590.
- Dunkel I.J., Aledo A., Kernan N.A., Kushner B. et al. Successful treatment of metastatic retinoblastoma // Cancer, 2000. V 89, N 10. — P. 2117−2121.
- Ek U. Emotional reactions in parents and children after diagnosis and treatment of malignant tumor in the eye // Child. Care. Health. Dev, 2000. -V 26, N5. P. 415 428.
- English M.W., Skinner R., Pearson A.D., Price L. Dose-related nephrotoxicity of carboplatin in children // Br.J. of Cancer, 1999. V 81, N2 — P. 336 -341.
- Francesco S., Mastrangelo D., Luca M.C. et al. Massive anterior chamber involvement in advanced retinoblastoma following intra-arterial chemotherapy // Acta Ophthalmologic^ 2012. -V 90 P. 249.
- Francis J.H., Rizzuti A.E., Abramson D.H. Chemotherapy for Retinoblastoma. Losing sight of visual outcome // Retinal Physician. 2009. — Issue: July 2009 http://www.retinalphysician.com/printarticle.aspx?articleID=103 202
- Franken field P.K. the power of humor and play as nursing interventions for child with cancer: a case report // J. Pediatr. Oncol. Hurs, 1996. -V 13, N 1. P. 15−20.
- Friedman D.L., Himelstein B., Shields C.L. et al, Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.// J Clin Oncol, 2000. -V 18. -P. 12−17.
- Gallie B.L. et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy // Arch. Ophthalmol, 1996. -V 114. P. 1321−1328.
- Gerinek A. Successful treatment of retinoblastoma // Cesk. Slov. Ophthalmol, 1997.-V 53, N3.-P. 168−173.
- Ghose S., Nizamuddin S.H., Sethi A. et al. Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities // J. Pediatr. Ophthalmol. Strasbimus, 2002. V 39. — P. 143−150.
- Gigantelli J.W. Enucleation and retinoblastoma: to what lengths must we go? // Arch. Ophthalmol, 2001. -V 119, N 1.-P.144−145.
- Gobin Y.P., Dunkel I.J., Marr B.P., et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. // Arch Ophthalmol, 2011. -V 129, N 6 -P.732−737.
- Gobin Y.P., Dunkel I.J., Marr B.P. et al. Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma // PLoS ONE, 2012. V 7, N 9. — P. 322.
- Gombos D.S., Kelly A., Coen P.G. et al Retinoblastoma treated with primary chemotherapy alone: the significance of tumor size, location and age// Br. J. Ophthalmol, 2002. -V 86.-P. 80−83.
- Hadjistilanou T., Greco G., Frezzotti R. Recurrent and new tumours during conservative treatment of bilateral retinoblastoma // Ophthalmic. Pediatr. Gent, 1991. -V 12, N2.-P. 79−84.
- Hadjistilianou T., Francesco S., Venturi C. et al. Direct intra-arterial (ophthalmic artery) chemotherapy with melphalan for advanced intraocular retinoblastoma: the Italian experience// Acta Ophthalmologica, 2010. -V 88 -P. 246.
- Harbour J.W., Murray T.G., Hamasaki D. et al. Local carboplatin therapy in transgenic murine retinoblastoma // Invest. Ophthalmol. Vis. Sci, 1996. V 37. -P. 1892−1989.
- Hathraf P., Kunavisarut S., Chuansumrit A., et al. Chemotherapy in patients with retinoblastoma // J. Med. Assoc. 1993. V 76, N 2 -P. 85−91.
- Hee M.R., Izatt J.A., Swanson E.A. et al. Optical coherence tomography of the human retina // Arch. Ophthalmol, 1995. V 113, No 3. — P.325−332.
- Hood D.C., Bach M., Brigell M., Keating D., Kondo M., Lyons J.S., Marmor M.F., McCulloch D.L., Palmowski-Wolfe A.M. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition) // Doc. Ophthalmol, 2012. -V 124.-P. 1−13.
- Huang D., Swanson E.A., Lin C.P. et al. Optical coherence tomography // Science, 1991. V 254, N 5035. — P. 1178−1181.
- Inomata M., Kaneko A., Chemosensitivity profiles of primary and cultured human retinoblastoma ceils in a human tumor clonogenic assay // Jpn. J. Cancer Res., 1987.-V 78. -P.858−868.
- J. Fernando Arevalo Retinal Angiography and Optical Coherence Tomography //Springer, 2009.-P. 369.
- Jahn C.G., Gobin Y.P., Marr B.P., et al. Enucleation after treatment with intraarterial chemotherapy for retinoblastoma: a report on 10 cases // ISOO meeting, Abstracts book, 2009. P. 289.
- Jonathan Kim, Do H., Egbert P. Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding. // Clin Ophthalmol, 2011. V 5 -P. 1655−1658.
- Kaneko A., Takayama J., Matsuoka H., et al. Chemothermotherapy was successful in two cases of recurrence of intraocular retinoblastoma after irradiation in Japanese., Rinsho Ganka, 1990. V 44. P. 289 -292.
- Kaneko A. Japanese contributions to ocular oncology // Int J Clin Oncol, 1999. -V4.-P. 321−326.
- Kingston, J.E., Hungerford J.L., Madreperla S.A. et al. // Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol, 1996. -V 114. P. 1339−1343.
- Kiribuchi M. Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors // in Japanese. Nippon Ganka Gakkai Zasshi, 1966. -V 70.-P.1829 -1833.
- Kivela T, Eskelin S, Paloheimo M, Intravitreal Methotrexate for Retinoblastoma // Helsinki, Finland Ophthalmology, 2011. -V 118, N 8. -P. 1689.
- Kochi M, Kitamura I, Goto T et al. Randomize comparison of intr-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma // J Neurooncol, 2000. -V 49. P. 63−70.
- Kondo M., Sieving P. Primate photopic sine-wave flicker ERG: vector modelling analysis of component origins using glutamate analogs // Invest. Ophthalmol. Vis. Sci, 2001. -V 42. -P. 305−312.
- Kupfer C. Retinoblastoma treated with intravenous nitrogen mustard // Am J Ophthalmol, 1953. -V 36. P. 1721−1723.
- Levy C., Doz F., Quintana E. et al. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results // Brit. J. Ophthalmol, 1998. V. 82. — P. 1154−1158.
- Lumbroso-Le Rouic L., Levy-Gabriel C., Desjardins L. et al. Conservative treatments of intraocular retinoblastoma // Ophthalmology, 2008. V 115, N 8. -P. 1405−1410.
- Madajewicz S, Chowhan N, Tfayli A et al. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. // Cancer, 2000. -V 88. -P. 2350−2356.
- Marec-Berard P., Khelfaoni F., Frappaz D., et al. Prolonged remisson in child with late brain methastasis of retinoblastoma // Arch. Pediatr, 1996. -V 3, N 10.-P. 1001−1005.
- Marmor M.F., Fulton A.B., Holder G.E., Miyake Y., Brigell M., Bach M. Standard for clinical electroretinography (2008 update) // Doc. Ophthalmol, 2009. -V. 118.-P. 69−77.
- McDaid C., Hartley S., Bagnall A.M. et al. Systematic review of effectiveness of different treatments for childhood retinoblastoma // Health Technol. Assess, 2005. V 9, N 48. -P. 1−145.
- Murphree A.L., Villablanca J.G., Deegan W.F., 3rd, Sato J.K., et.al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma // Arch. Ophthalmol, 1996. -V 114. P.1348−1356.
- Odom J.V., Bach M., Brigell M. et al. Vaegan. ISCEV standard for clinical visual evoked potentials (2009 update) // Doc Ophthalmol, 2010. V 120. — P. 111−119.
- Palazzi M., Abramson D.H., Ellsworth R.M. Endophytic vs exophytic unilateral retinoblastoma: is there any real difference? // J Pediatr Ophthalmol Strabismus, 1990. V 27, N 5. — P. 255−258.
- Petrilli A.S., Kechichian R., Broniscer A. et al. Activity of intraartrial car-boplatin as a single agent in the treatment of newly diagnosed extremity osteosarcoma // Medical and pediatric Oncology, 1999. -V 33, N 2. P. 71−75.
- Pham C.T., Blanc R, Lumbroso-Le Rouic L. et al. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma // Neuroradiology, 2012. -V 54, N8. -P. 845−848.
- Prados M.D., Warnick R.E., Mack E.E. Intravenous carboplatin for recurrent gliomas // Am. J. Clinical oncology, 1996. -V 19, N 6. P. 609−612.
- Puliafito C.A., Hee M.R., Schuman J.S. et al. Optical coherence tomography of ocular diseases.- New Jersey: Slack Incorporated, 1996. P.339−368.
- Rangaswamy N.V., Shirato S., Kaneko M. et al. Effects of spectral characteristics of Ganzfeld stimuli on the photopic negative response (PhNR) of the ERG // Invest. Ophthalmol. Vis. Sci, 2007. V 48. — P. 4818−4828.
- Reese AB, Hyman G, Tapley N, Forrest AW. The treatment of retinoblastoma by X-ray and triethylene melamine. AMA // Arch Ophthalmol, 1958. V 60. -P. 897−906.
- Ripps H., Carr R.E., Siegel I.M., Greenstein V.C. Functional abnormalities in vincristine-induced night blindness // Invest. Ophthalmol. Vis. Sci, 1984. V 25. — P. 787−794.
- Rizzuti A.E., Dunkel I.J., Abramson D.H. The adverse events of chemotherapy for retinoblastoma: what are they? Do we know? // Arch. Ophthalmol, 2008. V 126. — P. 862−865.
- Rodriguez-Galindo C., Chantada G.L., Haik B.G., et al. Treatment of Retinoblastoma: Current Status and Future Perspectives // Curr Treat Options Neurol, 2007. -V 9, N 4. P.294−307.
- Rodriguez-Galindo C., Wilson M.W., Haik B.G., et al C. Treatment of intraocular retinoblastoma with vincristine and carboplatin // J Clin Oncol, 2003. -V 21, N10.-P. 2019−2025.
- Ross G., Lipper E.G., Abramson D. H. et al. The development of young children with retinoblastoma // Arch. Pediatr. Adolesk. Med. Related articles, books, 2001. -V 155, N 1. P. 80−83.
- Schefler AC, Abramson DH. Retinoblastoma: what is new in 2007−2008. Curr Opin Ophthalmol, 2008. -VI9 P. 526 -534.
- Schiavetti A., Hadjistilianou T., Clerico A. et al. Conservative Therapy In Intraocular Retinoblastoma: Response Recurrence Rate // J. Pediatr.Hematol.Oncol, 2005. -V 27, N 1. P.3−6.
- Schueler AO, Fluhs D, Bornfeld N et al. p-Ray Brachytherapy with 106RU plaques for retinoblastoma.// Int. J. Radiation Oncology Biol. Phys, 2006. V 65,1461. N4.-P. 1213−1221.
- Schuman J.S., Puliafito C.A., Fujimoto J.G. Optical coherence tomography of ocular diseases. Ed.2. — Slack Inc., 2004. — P.714.
- Shapiro W.R., Green S.B., Burger P.C. et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5 fluoruracil, for newly diagnosed patients with malignant glioma // J Neurosurg, 1992. V 76 -P. 722−781.
- Shields C. Retinoblastoma requires strategy Appropriate chemotherapy choice based on understanding of treatment modalities // Ophthalmology times 2011.
- Shields C.L., Bianciotto C.G., Jabbour P., et al. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications // Arch. Ophthalmol, 2011.-V. 129, N 11.-P. 1407−1415.
- Shields C.L., De Potter P., Himelstein B.P., et al. Chemoreduction in the initial management of intraocular retinoblastoma. // Arch Ophthalmol, 1996. -V 114.-P. 1330−1338.
- Shields C.L., Honavar S.G., Meadows A.T., Shields J.A., Demirci H., Na-duvilath T.J. Chemoreduction for unilateral retinoblastoma // Arch. Ophthalmol, 2002.-V 120.-P. 1653−1658.
- Shields C.L., Mashayekhi A., Demirci H. et al., Practical approach to management of retinoblastoma. // Arch Ophthalmol, 2004. -V 122, N5. P. 729−735.
- Shields C.L., Mashayekhi A., Au A.K., et al. The International classification of retinoblastoma predicts chemoreduction success // Ophthalmology, 2006. -V 113, N 12.-P. 2276−2280.
- Shields C.L., Materin M.A., Shields J.A. Ocular oncology // Optical coherence tomography in retinal diseases / ed. Saxena S., Meredith T. A New Dehli: Medical Publishers. LTD, 2006. — P.251−269.
- Shields C.L., Meadows A.T., shields J.A., et al. Chemoreduction for retinoblastoma may prevent intracranial malignancy (trilateral retinoblastoma) // Arch. Ophthamol, 2001. -V 119, N 9. P. 1269−1272
- Shields C.L., Overview of retinoblastoma msnegment. // Abstr. Book of X ICOO. Amesterdam — P. 190−193.
- Shields C.L., Shields J.A., De Potter P. New treatment modalities for retinoblastoma //Current Opinion Ophthalmol., 1996. -V 7. P. 20−26
- Shields C.L., Shields J.A., Needle M. et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma // Ophthalmology, 1997. V 104.-P. 2101−2111.
- Shields J.A., Shields C.L., Donaso L.A. et al. Changing concepts in the management of retinoblastoma // Ophthalmic. Surg, 1990. -V 21. P. 72−76
- Shields C.L., Mashayekhi A., Cater J., et al. Macular retinoblastoma managed with chemoreduction // Arch Ophthalmol, 2005.-V 123. P.765−773.
- Shields C.L., Shields J.A., De Potter P., Needle M. Bilateral macular retinoblastoma managed by chemoreduction and chemothermotherapy //Arch. Ophthalmol, 1996. -V 114. P. 1426−1427.
- Shields C.L., Shields J.A., Needle M. et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma // Ophthalmology, 1997. V 104.-P. 2101−2111.
- Shields C.L., Ramasubramanian A., Rosenwasser R., Shields J.A. Superse-lective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma// Retina.- 2009.-V 29.- P. 1207−1209.
- Shields C.L., et al., Intra-arterial Chemotherapy for Retinoblastoma: Report No. 1, Control of Retinal Tumors, Subretinal Seeds and Vitreous Seeds. Arch. Ophthalmol, 2011.-V 129, N 11.-P. 1399−1406.
- Shields, C.L., Meadows A.T., Leahey A.M., et al., Continuing challenges in the management of retinoblastoma with chemotherapy // Retina, 2004, -V 24, N 6. P. 849−862.
- Shields C.L., Shields J.A., Baez K., et al. Optic nerve invasion of retinoblastoma // Cancer, 1994. -V 73, N 3. -P. 692−698.
- Sovinz P., Urban C., Lackner H., et al. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria //Klin Wochenschr, 2006. -V 118, N 1−2. P. 22−30.
- Stine K.C., Hockenbery M.J., Harrelson J. et al. Systemic doxorubicin and intra-arterial cisplatin presoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma // Cancer, 1989. -V 2. P. 1−16.
- Suzuki S., Kaneko A. Management of intraocular retinoblastoma and ocular prognosis // Int. J. Clin. Oncol., 2004. -V 9. P 1−6.
- Suzuki S., A. Kaneko Ocular and systemic prognosis of selective ophthalmic arterial injection for intraocular retinoblastoma //ISOO Meeting Cambridge, UK, 8−12 September, 2009. — P. 283.
- Suzuki S., Yamane T., Mohri M., Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis // Ophthalmology, 2011. V 118, N 10. — P. 2081−2087.
- The Committee for the National Registry of Retinoblastoma/ Survival rate and risk factors for patients with retinoblastoma in Japan // Jpn. J. Ophthalmol., 1992.-V 36, N2.-P. 121−131.
- Weiss A.H., Kelly J.P., Kapur R.P., Pendergrass T. Retinal function and corresponding pathology in advanced retinoblastoma // Arch. Ophthalmol, 2008. -V. 126.-P. 1507−1512.
- Yamane T., Kaneko A., Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma // Int. J. Clin. Oncol., 2004. -V 9, N 2. P.69−73.
- Zueva M., Tsapenko I., Pak N., Vaskov S. What does the flicker ERG reflect in rabbit retina? / Abstracts of 42nd ISCEV Symposium, Puerto-Rico, USA, 2004. P. 54.